Posts by: Alice Melão

News

Phio Pharmaceuticals and researchers with Helmholtz Zentrum München — the German Research Center for Environmental Health (HMGU) — are working together to develop new approaches to boost the immune system in fighting ... Read more

September 25, 2019

Bavencio-Inlyta Combo Recommended for Approval in EU for Advanced Kidney Cancer

News

The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended that a combination of Bavencio (avelumab) and Inlyta (axitinib) be approved for ... Read more

August 2, 2019

EMA Committee Favors Keytruda-Inlyta Combo for Advanced Kidney Cancer Patients

News

The Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), has recommended that a combination of Keytruda (pembrolizumab) and Inlyta (axitinib) be approved as a first-line treatment ... Read more

July 24, 2019

First Melanoma Patient Dosed with Syntrix’ SX-682 in Combo with Keytruda in Phase 1/2 Trial

News

Syntrix Pharmaceuticals has dosed the first patient in an ongoing Phase 1/2 clinical trial testing its experimental therapy SX-682 in combination with Keytruda (pembrolizumab) as a treatment for advanced melanoma, the ... Read more

July 23, 2019

PrimeVax Receives FDA’s OK to Use Dengue Virus for Cancer Treatment

News

The U.S. Food and Drug Administration (FDA) has approved three clinical studies testing PrimeVax Immuno-Oncology’s investigational approach using dendritic cells and dengue virus for cancer treatment. The investigational new drug ... Read more

July 12, 2019July 12, 2019

Libtayo Approved in Europe to Treat Metastatic or Advanced Cutaneous Squamous Cell Carcinoma

News

Libtayo (cemiplimab) has been conditionally approved to be sold in the European Union for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC), one of ... Read more

May 8, 2019

Gritstone to Move Slate Immunotherapy into Clinical Trial Sooner than Anticipated

News

Gritstone Oncology is advancing its investigational immunotherapy Slate into Phase 1 clinical studies sooner than planned, and expects patient enrollment to start as early as mid-2019, the company announced. This ... Read more

May 3, 2019

Sound Biologics to Launch Phase 1 Trial Assessing Its Candidate Immunotherapy for Solid Tumor Patients

News

Sound Biologics is launching a Phase 1 trial to test its candidate immunotherapy PSB205 in relapsed or refractory solid tumor patients, after the U.S. Food and Drug Administration cleared its investigational ... Read more

March 19, 2019

Alligator Bioscience Starts Phase 1 Trial to Test ATOR-1015 in Advanced Solid Tumors

News

The first patient has been dosed in Alligator Bioscience’s Phase 1 clinical trial testing the investigational immunotherapy ATOR-1015 as a new treatment for advanced solid tumors, the company announced. The open-label trial ... Read more

March 15, 2019

TC BioPharm, Trinity College Dublin Pair to Develop Cancer-fighting Cell Therapy

News

TC BioPharm (TCB) and Trinity College Dublin researchers are working together to expedite the production of V delta 1 γδ T cells to be used in the fight against solid tumors. TCB’s ... Read more